GCM
Gladius Capital Management Portfolio holdings
AUM
$63.8M
1-Year Return
3.49%
This Quarter Return
+1.19%
1 Year Return
+3.49%
3 Year Return
+10.82%
5 Year Return
+16.08%
10 Year Return
+49.7%
AUM
$325M
AUM Growth
+$9.02M
(+2.9%)
Cap. Flow
-$2.14M
Cap. Flow
% of AUM
-0.66%
Top 10 Holdings %
Top 10 Hldgs %
80.31%
Holding
367
New
58
Increased
82
Reduced
141
Closed
69
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$91.5M |
| 2 |
Invesco QQQ Trust
QQQ
|
$17.1M |
| 3 |
JPMorgan Chase
JPM
|
$6.07M |
| 4 |
Bank of America
BAC
|
$4.11M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$4.05M |
Top Sells
| 1 |
Apple
AAPL
|
$30.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$28.1M |
| 3 |
UnitedHealth
UNH
|
$22.5M |
| 4 |
NVIDIA
NVDA
|
$13.6M |
| 5 |
Walmart
WMT
|
$11M |
Sector Composition
| 1 | Financials | 6.83% |
| 2 | Healthcare | 5.61% |
| 3 | Consumer Staples | 3.91% |
| 4 | Technology | 3.24% |
| 5 | Consumer Discretionary | 2.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
NACCO Industries
NC
$287M
| $34.7K | ﹤0.01% |
+961
| New | +$34.7K |
|
177
Phibro Animal Health
PAHC
$1.6B
| $34.7K | ﹤0.01% |
2,262
-826
| -27% | -$12.7K |
|
178
Theravance Biopharma
TBPH
$694M
| $34.6K | ﹤0.01% |
3,190
-363
| -10% | -$3.94K |
|
179
Prestige Consumer Healthcare
PBH
$3.29B
| $34.6K | ﹤0.01% |
552
-66
| -11% | -$4.13K |
|
180
NETGEAR
NTGR
$810M
| $34.4K | ﹤0.01% |
1,859
-47
| -2% | -$870 |
|
181
Insteel Industries
IIIN
$747M
| $34.3K | ﹤0.01% |
1,233
-45
| -4% | -$1.25K |
|
182
Perrigo
PRGO
$3.21B
| $34.2K | ﹤0.01% |
953
-220
| -19% | -$7.89K |
|
|
BBUC
183
Brookfield Business Corp
BBUC
$2.33B
| $34.2K | ﹤0.01% |
1,724
-1
| -0.1% | -$20 |
|
184
Revvity
RVTY
$9.82B
| $33.7K | ﹤0.01% |
+253
| New | +$33.7K |
|
|
ARCH
185
DELISTED
Arch Resources, Inc.
ARCH
| $33.4K | ﹤0.01% |
254
+4
| +2% | +$526 |
|
186
Rayonier Advanced Materials
RYAM
$371M
| $33.3K | ﹤0.01% |
+5,314
| New | +$33.3K |
|
187
Cato Corp
CATO
$86.2M
| $33.3K | ﹤0.01% |
3,764
-504
| -12% | -$4.46K |
|
188
McDonald's
MCD
$228B
| $33K | ﹤0.01% |
118
-1,546
| -93% | -$432K |
|
189
Diamond Hill
DHIL
$391M
| $32.9K | ﹤0.01% |
200
-17
| -8% | -$2.8K |
|
190
DXP Enterprises
DXPE
$1.95B
| $32.8K | ﹤0.01% |
1,219
-257
| -17% | -$6.92K |
|
|
PDCO
191
DELISTED
Patterson Companies, Inc.
PDCO
| $32.8K | ﹤0.01% |
1,224
-77
| -6% | -$2.06K |
|
192
Rimini Street
RMNI
$401M
| $32.7K | ﹤0.01% |
+7,925
| New | +$32.7K |
|
193
Delek US
DK
$1.95B
| $32.5K | ﹤0.01% |
+1,415
| New | +$32.5K |
|
194
Ironwood Pharmaceuticals
IRWD
$179M
| $32.3K | ﹤0.01% |
3,072
-104
| -3% | -$1.09K |
|
|
NWLI
195
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $32.3K | ﹤0.01% |
133
-47
| -26% | -$11.4K |
|
196
F&G Annuities & Life
FG
$4.74B
| $32.1K | ﹤0.01% |
+1,769
| New | +$32.1K |
|
197
Innoviva
INVA
$1.32B
| $32K | ﹤0.01% |
2,846
-65
| -2% | -$731 |
|
198
Vanda Pharmaceuticals
VNDA
$272M
| $32K | ﹤0.01% |
4,707
+1,229
| +35% | +$8.35K |
|
199
HF Sinclair
DINO
$9.69B
| $31.8K | ﹤0.01% |
657
+40
| +6% | +$1.94K |
|
200
Hudson Technologies
HDSN
$455M
| $31.4K | ﹤0.01% |
+3,597
| New | +$31.4K |
|